Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Who are the new users of antipsychotic medications?

Domino ME, Swartz MS.

Psychiatr Serv. 2008 May;59(5):507-14. doi: 10.1176/ps.2008.59.5.507.

2.

Utilization and costs of antipsychotic agents: a Canadian population-based study, 1996-2006.

Alessi-Severini S, Biscontri RG, Collins DM, Kozyrskyj A, Sareen J, Enns MW.

Psychiatr Serv. 2008 May;59(5):547-53. doi: 10.1176/ps.2008.59.5.547.

PMID:
18451015
3.

Changes in drug coverage generosity and untreated serious mental illness: transitioning from Medicaid to Medicare Part D.

Madden JM, Adams AS, LeCates RF, Ross-Degnan D, Zhang F, Huskamp HA, Gilden DM, Soumerai SB.

JAMA Psychiatry. 2015 Feb;72(2):179-88. doi: 10.1001/jamapsychiatry.2014.1259.

4.

Healthcare costs of atypical antipsychotic use for patients with bipolar disorder in a Medicaid programme.

Qiu Y, Fu AZ, Liu GG, Christensen DB.

Appl Health Econ Health Policy. 2010;8(3):167-77. doi: 10.2165/11318830-000000000-00000.

PMID:
20408601
5.

Off-label use of antipsychotic medications in Medicaid.

Leslie DL, Rosenheck R.

Am J Manag Care. 2012 Mar 1;18(3):e109-17.

6.

Trends in the rate and type of antipsychotic medications prescribed to persons with schizophrenia.

Rothbard AB, Kuno E, Foley K.

Schizophr Bull. 2003;29(3):531-40.

PMID:
14609246
7.

[Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].

Bret P, Bret MC, Queuille E.

Encephale. 2009 Apr;35(2):129-38. doi: 10.1016/j.encep.2008.03.007. Epub 2008 Jul 7. French.

PMID:
19393381
8.

Pharmaco-utilisation and related costs of drugs used to treat schizophrenia and bipolar disorder in Italy: the IBIS study.

Degli Esposti L, Sangiorgi D, Mencacci C, Spina E, Pasina C, Alacqua M, la Tour F.

BMC Psychiatry. 2014 Oct 14;14:282. doi: 10.1186/s12888-014-0282-z.

9.

Prevalence of antipsychotic prescriptions among patients with anxiety disorders treated in inpatient and outpatient psychiatric settings.

Weber SR, Wehr AM, Duchemin AM.

J Affect Disord. 2016 Feb;191:292-9. doi: 10.1016/j.jad.2015.11.031. Epub 2015 Nov 26.

PMID:
26688499
10.

Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.

Citrome L, Kalsekar I, Guo Z, Laubmeier K, Hebden T.

Clin Ther. 2013 Dec;35(12):1867-75. doi: 10.1016/j.clinthera.2013.09.006. Epub 2013 Oct 8.

11.

Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia.

Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, Jeste DV.

Am J Psychiatry. 2004 Apr;161(4):692-9.

PMID:
15056516
12.
13.

Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in Medicaid.

Seabury SA, Goldman DP, Kalsekar I, Sheehan JJ, Laubmeier K, Lakdawalla DN.

Am J Manag Care. 2014 Feb 1;20(2):e52-60.

14.

Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002.

Mirandola M, Andretta M, Corbari L, Sorio A, Nosè M, Barbui C.

Pharmacoepidemiol Drug Saf. 2006 Jun;15(6):412-20.

PMID:
16287199
15.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
16.

Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.

Loosbrock DL, Zhao Z, Johnstone BM, Morris LS.

J Ment Health Policy Econ. 2003 Jun;6(2):67-75.

PMID:
14578539
17.

Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.

Van Dorn RA, Andel R, Boaz TL, Desmarais SL, Chandler K, Becker MA, Howe A.

J Clin Psychiatry. 2011 Apr;72(4):502-8. doi: 10.4088/JCP.10m06618.

PMID:
21527125
18.
19.

Use of administrative data to identify off-label use of second-generation antipsychotics in a Medicaid population.

Hartung DM, Middleton L, McFarland BH, Haxby DG, McDonagh MS, McConnell KJ.

Psychiatr Serv. 2013 Dec 1;64(12):1236-42. doi: 10.1176/appi.ps.005482012.

PMID:
23999754
20.

The relationship between mental health diagnosis and treatment with second-generation antipsychotics over time: a national study of U.S. Medicaid-enrolled children.

Matone M, Localio R, Huang YS, dosReis S, Feudtner C, Rubin D.

Health Serv Res. 2012 Oct;47(5):1836-60. doi: 10.1111/j.1475-6773.2012.01461.x. Epub 2012 Sep 4.

Supplemental Content

Support Center